These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24518673)

  • 41. Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis.
    Müller AM; Jun E; Conlon H; Sadiq SA
    BMC Neurosci; 2012 Mar; 13():30. PubMed ID: 22436018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The neuropeptide alpha-melanocyte-stimulating hormone: a key component of neuroimmunomodulation.
    Catania A; Lipton JM
    Neuroimmunomodulation; 1994; 1(2):93-9. PubMed ID: 7489326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the immunogenicity of the synthetic α-melanocyte-stimulating hormone (α-MSH) analogue afamelanotide ([Nle4-D-Phe7]-α-MSH, Scenesse®) in erythropoietic protoporphyria patients by ELISA detecting both anti-afamelanotide and anti-α-MSH antibodies.
    Lengweiler S; Kreim S; Barman-Aksözen J; Maurer M; Minder EI
    Skin Pharmacol Physiol; 2015; 28(2):103-13. PubMed ID: 25402764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropeptide α-Melanocyte-Stimulating Hormone Promotes Neurological Recovery and Repairs Cerebral Ischemia/Reperfusion Injury in Type 1 Diabetes.
    Goit RK; Ng TC; Tam KC; Tsang JKW; Taylor AW; Lo ACY
    Neurochem Res; 2022 Feb; 47(2):394-408. PubMed ID: 34586586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. alpha-Melanocyte-stimulating hormone and acute renal failure.
    Kohda Y; Chiao H; Star RA
    Curr Opin Nephrol Hypertens; 1998 Jul; 7(4):413-7. PubMed ID: 9690041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stimulating the Melanocortin System in Uveitis and Diabetes Preserves the Structure and Anti-Inflammatory Activity of the Retina.
    Ng TF; Taylor AW
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-inflammatory Properties of the Alpha-Melanocyte-Stimulating Hormone in Models of Granulomatous Inflammation.
    Shahraki AH; Tian R; Zhang C; Fregien NL; Bejarano P; Mirsaeidi M
    Lung; 2022 Aug; 200(4):463-472. PubMed ID: 35717488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of host defense by the neuropeptide alpha-MSH.
    Lipton JM
    Yale J Biol Med; 1990; 63(2):173-82. PubMed ID: 2205057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alpha-melanocyte-stimulating hormone peptides in host responses. From basic evidence to human research.
    Catania A; Lipton JM
    Ann N Y Acad Sci; 1993 May; 680():412-23. PubMed ID: 8390161
    [No Abstract]   [Full Text] [Related]  

  • 50. The Neuropeptides of Ocular Immune Privilege, α-MSH and NPY, Suppress Phagosome Maturation in Macrophages.
    Benque IJ; Xia P; Shannon R; Ng TF; Taylor AW
    Immunohorizons; 2018 Nov; 2(10):314-323. PubMed ID: 30613828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria.
    Minder EI; Schneider-Yin X
    Expert Rev Clin Pharmacol; 2015 Jan; 8(1):43-53. PubMed ID: 25470471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Neuropeptide α-Melanocyte-Stimulating Hormone Prevents Persistent Corneal Edema following Injury.
    Alemi H; Wang S; Blanco T; Kahale F; Singh RB; Ortiz G; Musayeva A; Yuksel E; Pang K; Deshpande N; Dohlman TH; Jurkunas UV; Yin J; Dana R
    Am J Pathol; 2024 Jan; 194(1):150-164. PubMed ID: 37827217
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery and development of novel melanogenic drugs. Melanotan-I and -II.
    Hadley ME; Hruby VJ; Blanchard J; Dorr RT; Levine N; Dawson BV; al-Obeidi F; Sawyer TK
    Pharm Biotechnol; 1998; 11():575-95. PubMed ID: 9760697
    [No Abstract]   [Full Text] [Related]  

  • 54. [The role of alpha-melanocyte-stimulating hormone in neuroimmunomodulation].
    Jin L; Wang BR; Ju G
    Sheng Li Ke Xue Jin Zhan; 2000 Jan; 31(1):53-6. PubMed ID: 12532769
    [No Abstract]   [Full Text] [Related]  

  • 55. An α-MSH analog in erythropoietic protoporphyria.
    Luger TA; Böhm M
    J Invest Dermatol; 2015 Apr; 135(4):929-931. PubMed ID: 25785940
    [No Abstract]   [Full Text] [Related]  

  • 56. Antiinflammatory effects of the neuropeptide alpha-MSH in acute, chronic, and systemic inflammation.
    Lipton JM; Ceriani G; Macaluso A; McCoy D; Carnes K; Biltz J; Catania A
    Ann N Y Acad Sci; 1994 Nov; 741():137-48. PubMed ID: 7825801
    [No Abstract]   [Full Text] [Related]  

  • 57. Enhancement of Candida albicans killing activity of separated human epidermal cells by alpha-melanocyte stimulating hormone.
    Csato M; Kenderessy AS; Dobozy A
    Br J Dermatol; 1989 Jul; 121(1):145-7. PubMed ID: 2547421
    [No Abstract]   [Full Text] [Related]  

  • 58. A conformational study of two cyclic peptide analogues of alpha-MSH.
    Forsyth G; Branch S; Moss S; Notarianni L; Osguthorpe D; Pouton C
    Ann N Y Acad Sci; 1993 May; 680():517-9. PubMed ID: 8390181
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinuvel's tanning agent nears approval for porphyria.
    Mullard A
    Nat Biotechnol; 2015 Jan; 33(1):7. PubMed ID: 25574616
    [No Abstract]   [Full Text] [Related]  

  • 60. Experimental autoimmune oophoritis and α-melanocyte-stimulating hormone.
    Ayala C; Celis ME
    Expert Rev Endocrinol Metab; 2010 Jul; 5(4):539-547. PubMed ID: 30780797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.